J.ophthalmol.(Ukraine).2019;6:70-75.

http://doi.org/10.31288/oftalmolzh201967075

Received: 17 October 2019; Published on-line: 08 January 2020


A case report of uveitis with ocular hypertension

N. V. Konovalova, Dr. Sc. (Med.); V. V. Savko, Dr. Sc. (Med.); N. I. Khramenko, Cand. Sc. (Med.); O. V. Guzun, Cand. Sc. (Med.); S. B. Slobodianyk, Cand. Sc. (Med.); Iu. A. Zhuravok, Cand. Sc. (Med.); V. V. Savko, Jr., Cand. Sc. (Med.)

SI "The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine"; Odesa (Ukraine)

E-mail:  kvnkonovalova@gmail.com

TO CITE THIS ARTICLE: Konovalova NV, Savko VV, Khramenko NI, Guzun OV, Slobodianyk SB, Zhuravok IuA, Savko VV, Jr. A case report of uveitis with ocular hypertension. J.ophthalmol.(Ukraine).2019;6:70-75. http://doi.org/10.31288/oftalmolzh201967075


Based on a clinical case, we analyzed the characteristics of diagnosis, course, and treatment of uveitis in the presence of ocular hypertension.

Keywords: uveitis, ocular hypertension, prostaglandin analogues

References:

1.Arbenyeva NS, Chekhova TA, Bratko GV, Chernakh VV. [Comparative analysis of diseases incidence in patients with uveitis]. [The Annual All-Russian Scientific Practical Conference of Young Scientists «Current Problems of Ophthalmology». Abstract book]. M.: Oftalmologiia; 2012: 28-29. In Russian 

2.Drozdova EA. [The classification and epidemiology of uveitis]. RMZh. Klinicheskaia Oftalmologiia; 2016;3:155-9. In Russian.    

Crossref 

3.Panova IE, Drozdova EA. [Uveitis: Guidance for practitioners]. M.: Meditsinskoie informatsionnoie agenstvo; 2014. 144p. In Russian.  

4.Аnamori A, Naka M, Fukuda M et al. Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo. Exp. Eye Res. 2009;88(3):535–41

Crossref   PubMed

5.Asrani S, Moore DB, Jaffe GJ. Paradoxical changes of retinal nerve fiber layer thickness in uveitic glaucoma. JAMA Ophthalmology. 2014; 132(7): 877–80. doi: 10.1001/jamaophthalmol.2014.954.

Crossref   PubMed 

6.Boltz A, Schmidl D, Weigert G et al. Effect of latanoprost on choroidal blood flow regulation in healthy subjects.Invest. Ophthalmol. Vis. Sci. 2011;52(7):4410–5. 

Crossref   PubMed 

7.Horsley MB, Chen TC. The use of prostaglandin analogs in the uveitis patient. Seminars in Ophthalmology. 2011;26(4-5):285–9.

Crossref   PubMed  

8.Kurashima H, Watabe H, Sato N et al. Effects of prostaglandin F(2α) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: comparison among tafluprost, travoprost, and latanoprost. Exp. Eye Res. 2010; 91(6):853–9.

Crossref   PubMed  

9.Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G. Efficacy and safety of latanoprost in eyes with uveitis glaucoma. Graefe's Arch for Clin and Exp Ophthalmol. 2009;247(6):775–80.

Crossref   PubMed   

10.Nakanishi Y, Nakamura M, Mukuno H et al. Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mutagen-activated protein kinas. Exp. Eye Res. 2006;83(5):1108–17. 

Crossref   PubMed  

11.Takeuchi M, Kanda T, Taguchi M et al.  Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis. Ocul Immunol Inflamm. 2017; Feb 25 (1):105-10.

Crossref   PubMed